Pharmageddon :Part XII

Drug company GlaxoSmithKline is to buy Human Genome Sciences for about

$3bn, ending a three-month pursuit of the US biotechnology firm....

GSK will gain control of Benlysta :

which treats the immune system disorder lupus

as well as experimental medicines for diabetes and heart disease.

The drugs industry has seen several takeovers and mergers recently  ::redcard::

                   

Bristol-Myers Squibb recently bought diabetes specialist Amylin Pharmaceuticals !

I have a few new ones saved up.  here:


http://www.dw.de/dw/article/0,,1220847,00.html

and here:


http://www.digitaljournal.com/article/323371

http://truthman30.wordpress.com/2012/01/...f-england/